Orchid Chemicals & Pharmaceuticals Ltd
Audited Financial Results for the year ended March 31, 2002
Rs.Lakhs
Sl No Particulars
Three Months Ended
31.03.2002
Three Months Ended
31.03.2001
Year Ended 31.03.2002
(Audited)
Year Ended 31.03.2001
(Audited)
1
 Sales and Operating Income
14717.61
10071.29
42552.48
37124.92
2
 Other Income
18.88
21.89
75.32
131.22
3
 Total Expenditure
12385.45
7455.07
33365.74
27450.85
a) Decrease/(Increase) in Stock in trade
(1822.85)
(1883.55)
(2266.84)
(3753.92)
b) Consumption of raw materials
10038.11
6336.20
23514.95
21129.43
c) Staff Cost
727.21
721.11
2506.10
2188.42
d) Other Expenditure
3442.98
2281.31
9611.53
7886.92
4
Gross Profit before Interest, Depreciation & Extraordinary items (1+2-3)
2351.04
2638.11
9262.06
9805.29
5
Provision for doubtful debts
895.43
1195.43
6
 Interest and Finance Charges
633.47
822.22
3141.56
3043.20
7
 Depreciation
1025.14
790.62
3582.15
3116.31
8
 Profit before tax (4-5-6-7)
(203.00)
1025.27
1342.92
3645.78
9
 Provision for Taxation
  -Current Tax
-
-
-
70.04
  -Deferred Tax
208.92
-
712.30
-
10
 Net Profit (8-9)
(411.92)
1025.27
630.62
3575.74
11
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
2799.92
2799.92
2799.92
2,799.92
12
 Reserves excluding Revaluation Reserves
30137.32
36964.65
13
 Basic Earnings per Share (Rs.)
(1.47)
3.66
2.25
12.77
14
 Aggregate of Non-Promoter shareholding
3.77
- Number of equity shares of Rs.10/- each
23358770
23319637
  - Percentage of shareholding
83.43
83.29
       
 
  SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
(Rs.Lakhs)
  Particulars
Three Months Ended
31-03-02
Year Ended
31-03-02
  1. Segment Revenue  
  a. Bulk
14320.83
41273.30
  b. Formulations
596.53
2216.28
  Total
14917.36
43489.58
  Less: Inter segment revenue
199.75
937.10
  Net Sales / Income from Operations
14717.61
42552.48
     
  2. Segment Results
  a. Bulk
646.74
5053.98
  b. Formulations
(234.80)
(636.00)
  Total
411.94
4417.98
  Less:
  i) Interest (Net)
633.46
3141.56
  ii) Other unallocable expenditure net off unallocable income
(18.52)
(66.50)
  Total Profit Before Tax
(203.00)
1342.92
 
  3. Capital Employed
  a. Bulk
13759.31
73590.02
  b. Formulations
908.60
2786.11
  Total
14667.91
76376.13
 
  1. The above financial results were adopted by the Board of Directors at its meeting held on Wednesday, May 29, 2002.
  2. The Board of Directors has recommended a dividend of 40% ( Rs 4 per share) on the equity share of Rs 10 each.
  3. In accordance with the requirements of the new Accounting Standard 22 issued by the Institute of Chartered Accountants of India, relating to provision for deferred tax, the deferred tax liability relating to previous years amounting to Rs 63.38 Crores has been adjusted against the reserves as on April 01, 2001. Deferred tax liability for the current year has been provided as per the said Accounting Standard.
  4. Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : 29-05-2002

For and on behalf of the Board

K.Raghavendra Rao
Managing Director